Microbiology
Review Provides Insight into Therapeutic Interventions
A new review has outlined recommendations and a gold standard for identifying at-risk patients who are critically ill, or in receipt of organ transplants, for preventing, diagnosing and treating invasive fungal infections. It was published as part of a set of papers intended to provide new insights into the breadth of serious fungal diseases and as a call to world health bodies to prevent millions of infections each year. More...21 Aug 2017
Expanded Pathogen Identification Receives FDA Clearance
Mycobacteria, Nocardia and molds are complex organisms to identify, requiring days or weeks of specific culture conditions for appropriate growth and subsequent advanced methods for reliable identification to the species level. More...15 Aug 2017
Three Commercial Tests for Lyme Borreliosis Evaluated
The recommended approach for the diagnosis of Lyme borreliosis consists of screening for Borrelia-specific serum antibodies with an enzyme-linked immunosorbent assay (ELISA), followed by immunoblot confirmation of equivocal or positive ELISA results. More...15 Aug 2017
Molecular Tests Predict TB Treatment Outcome
New molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis (TB) impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure has remained unclear. Researchers have now found that molecular tests that detect resistance to the fluoroquinolones class of TB drugs may be at least as good as traditional drug-sensitivity tests conducted with lab cultures. More...14 Aug 2017
Test Discriminates Between Viral and Bacterial Infections
Lower respiratory tract infection (LRTI) commonly causes hospitalization in adults but because bacterial diagnostic tests are not accurate, antibiotics are frequently prescribed. Antibiotics are lifesaving drugs, but overuse is leading to antibiotic resistance, one of the world's most pressing health threats. More...10 Aug 2017
Methods Compared for Chagas Disease Diagnosis
Chagas Disease (CD) is a chronic infectious disease caused by the protozoan flagellate Trypanosoma cruzi. In endemic countries, CD is transmitted mainly through the contact with feces of different triatomine bugs. Due to increased migration, CD has become an international health problem. More...08 Aug 2017
New
Gold Member
Latex Test
SLE-Latex Test
New
Automated Microscope
dIFine
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
In Other News
TB Screening Recommended for High-Risk Healthcare Workers Only
New Test Distinguishes Zika from Similar Viral Infections
Powassan Virus Diagnosed in Patients with Tick-Borne Diseases
Antimicrobial Therapy Biomarker Enumerates Eosinophil Count Changes
Accuracy of Malaria Tests Evaluated for Febrile Children
Efficacy Evaluated in Maternal Screening for Congenital CMV
Antibody-Based ELISA Detects Zika with High Specificity
Novel Non-Invasive Sampling Technique Diagnoses Cutaneous Leishmaniasis
RT-PCR Evaluated for Taenia Detection
Bacterium Actively Drives CRC Tumor Growth
Rapid Diagnostic Test for RSV Evaluated
Heart Failure Associated with Depleted Intestinal Microbiota
CE-Marked Immunoassay Rapidly Detects Infection Biomarkers
Assay Detects Fish Trematode DNA in Human Stools
Assays Evaluated for Early Diagnosis of Leptospirosis
Toxoplasmosis POC Test Compared to Conventional Testing
FDA Approves Fourth-Generation Blood Test
Women with HIV Frequently Pass CMV to Infant
Immunoassay Developed for Acute Typhoid Fever
HIV Testing Peaks with Charlie Sheen Disclosure
PCR Test for Vaginal Pathogens Approved for Use
Cytokine Profile Differentiates Hantaviral Infections
Simple Method Measures Bacterial Tolerance to Antibiotics
The LabMedica Microbiology channel provides the latest news in the fields of epidemiology, bacteriology, virology, and parasitology, all viewed from the unique perspective of Laboratory Medicine.
